Author: Lindsey Smith
Stability Testing Requirements: Temperature and Time Conditions for Drug Products
By Lindsey Smith On 24 Feb, 2026 Comments (3)
Stability testing for pharmaceuticals requires strict temperature and time conditions to ensure drug safety and efficacy. ICH Q1A(R2) sets global standards for long-term, accelerated, and intermediate testing, with precise humidity and temperature controls. Failure to comply can lead to recalls, delays, or regulatory action.
View MoreInternational Perspectives on NTI Generics: Regulatory Approaches Compared
By Lindsey Smith On 22 Feb, 2026 Comments (5)
NTI generics require strict regulatory oversight due to their narrow margin between effective and toxic doses. This article compares how the FDA, EMA, Canada, Japan, and others regulate these high-risk medications, and why global harmonization is critical for patient safety.
View MoreFalls Risk on Anticoagulants: How to Prevent and Monitor Without Stopping Treatment
By Lindsey Smith On 21 Feb, 2026 Comments (6)
Falls don't mean you should stop blood thinners. Learn why DOACs are safer for older adults, how to reduce fall risk without stopping medication, and when anticoagulation is truly necessary for stroke prevention.
View MoreHow to Safely Use Short-Term Medications After Surgery
By Lindsey Smith On 17 Feb, 2026 Comments (10)
Learn how to safely use short-term medications after surgery with clear, actionable steps backed by CDC, ISMP, and WHO guidelines. Avoid common errors, protect yourself, and reduce risks of harm.
View MoreGeneric combination products: when multiple generics equal one brand
By Lindsey Smith On 15 Feb, 2026 Comments (0)
Generic combination products blend drugs and devices, but current substitution rules don't match the science. Patients pay more, face delays, and risk improper dosing because generics can't be mixed and matched like pills.
View MoreAsthma and COPD Inhalers: How to Use Them Correctly for Better Results
By Lindsey Smith On 14 Feb, 2026 Comments (9)
Learn how to use asthma and COPD inhalers correctly to get the full benefit of your medication. Most people use them wrong - here’s how to fix it.
View MoreCombination Therapy: How Lower Doses of Multiple Medications Reduce Side Effects and Improve Outcomes
By Lindsey Smith On 10 Feb, 2026 Comments (8)
Combination therapy uses lower doses of multiple medications to treat chronic conditions more effectively with fewer side effects. Proven in hypertension, diabetes, and cancer, it improves outcomes and adherence - especially with single-pill combos.
View MoreSterile Manufacturing: Special Requirements for Injectable Pharmaceuticals
By Lindsey Smith On 8 Feb, 2026 Comments (10)
Sterile manufacturing for injectables demands extreme controls to prevent contamination that can cause death. Learn the technical, regulatory, and operational requirements behind life-saving injectable drugs.
View MoreOpioids in Liver Disease: How Metabolism Changes and Why Side Effects Increase
By Lindsey Smith On 7 Feb, 2026 Comments (15)
Opioids can become dangerously toxic in liver disease due to impaired metabolism. Morphine and oxycodone accumulate, increasing overdose risk. Dosing must be adjusted based on liver function, and patches may be safer than pills.
View MoreAlcohol and Opioids: The Deadly Risk of Mixing Them
By Lindsey Smith On 7 Feb, 2026 Comments (15)
Mixing alcohol and opioids can cause fatal respiratory depression-even at low doses. Learn how this deadly combination works, who’s at risk, and why there’s no safe amount.
View MoreOpioid-Induced Adrenal Insufficiency: Symptoms, Diagnosis, and Treatment
By Lindsey Smith On 5 Feb, 2026 Comments (8)
Opioid-induced adrenal insufficiency is a rare but serious side effect of long-term opioid use. Learn about symptoms, diagnosis, and treatment options to prevent life-threatening complications.
View MoreFDA Import Alerts: How the U.S. Blocks Unsafe Drugs from Non-Compliant Manufacturers
By Lindsey Smith On 4 Feb, 2026 Comments (12)
The FDA's Import Alert system blocks unsafe drugs by detaining shipments from non-compliant manufacturers. Recent actions against GLP-1 weight-loss drugs show how strict enforcement works, with $1.84B in refused shipments in two months. Learn how manufacturers navigate compliance and why this matters for drug safety.
View More
